[PHARM] Drugs for Movement Disorders [Kruse] Flashcards
B. Parkinson Disease
C. Substantia nigra
How can individuals with parkinsons disease be treated?
Agents that activate dopamine receptors
and/or
Block muscarinic receptors
B. Carbidopa
What is carbidopa?
DOPA decarboxylase inhibitor
It does NOT cross the blood-brain barrier
It overall increases the half life, plasma levels and levodopa available for entry into the brain —–> This REDUCES the daily requirements of levodopa
D. Multiple episodes of immboility per day
E. Tolcapone
A. Hepatotoxicity
C. On-off phenomenon
B. Apomorphine
(Only injectable)
B. Dopamine (D2)
Apomorphine is a DA agonist
A. Amantadine
B. To help correct further the dopamine-ACh imbalance that accounts for parkinsonian signs and symptoms
C. Add benztropine